+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Astellas Pharma, Inc. - logo

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

From
From
From
From
Tissue Engineering and Regeneration Market 2024-2028 - Product Thumbnail Image

Tissue Engineering and Regeneration Market 2024-2028

  • Report
  • July 2024
  • 175 Pages
  • Global
From
Pigmentation Disorders Treatment Market Report 2025 - Product Thumbnail Image

Pigmentation Disorders Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Pruritus Therapeutics Market Report 2025 - Product Thumbnail Image

Pruritus Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Stargardt Disease (STGD) - Pipeline Insight, 2024 - Product Thumbnail Image

Stargardt Disease (STGD) - Pipeline Insight, 2024

  • Clinical Trials
  • November 2024
  • 240 Pages
  • Global
From
Recombinant Proteins Market Report 2023-2033 - Product Thumbnail Image

Recombinant Proteins Market Report 2023-2033

  • Report
  • April 2023
  • 353 Pages
  • Global
From
Tracheitis Treatment Market Report 2025 - Product Thumbnail Image

Tracheitis Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Bio-pharma Market 2024-2028 - Product Thumbnail Image

Bio-pharma Market 2024-2028

  • Report
  • December 2023
  • 184 Pages
  • Global
From
Synthetic Biology Market Report 2024-2034 - Product Thumbnail Image

Synthetic Biology Market Report 2024-2034

  • Report
  • July 2024
  • 402 Pages
  • Global
From
From
Loading Indicator